[Endovascular treatment of large and XXXX using flow-diverting stents].

@entity1 @entity63 @entity439 @entity715 @entity438
AIM: The objective was to evaluate the efficacy of treatment of @entity1 with large and @entity438 using flow-diverting stents (FDSs). MATERIAL AND METHODS: The treatment outcomes of 210 @entity1 with large and @entity438 were analyzed. The study included @entity1 with both asymptomatic and symptomatic @entity439 (manifested by SAH or pseudotumorous course). The rate of @entity439 was 62.3%. RESULTS: The technical success rate was 96%. In the perioperative period, the rate of clinically significant complications was 2.8%; the postoperative mortality was 3.3%. In the long-term period, total @entity715 of the @entity439 was observed in the majority of cases (80%) in the period from 4 to 12 months. Complete regression of clinical symptoms was observed in 26% of the cases, partial regression in 35%, and deterioration in 6% (of them, 4.9% of the cases were clinically significant). The long-term mortality was 2.5%. CONCLUSION: FDS is a highly efficient device for remodeling of the arterial lumen at the level of large, giant and fusiform @entity438 that significantly reduces the number of deconstructive operations and decreases the risk of @entity63 complications of endovascular treatment for this complex vascular pathology.
